Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 25980
Gene Symbol: AAR2
AAR2
0.100 GeneticVariation group CLINVAR
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.100 Biomarker group HPO
Entrez Id: 37
Gene Symbol: ACADVL
ACADVL
0.100 Biomarker group HPO
Entrez Id: 70
Gene Symbol: ACTC1
ACTC1
0.010 Biomarker group BEFREE The frequencies of II (Insertion/Insertion) genotype in the ASD and VSD patients were significantly higher than that of controls (p=0.004 for ASD Vs. controls, and p=0.009 for VSD Vs. controls, respectively), and the frequencies for I allele in CHD patients were also significantly higher than that in controls (p=0.01 for ASD Vs. controls, and p=0.009 for VSD Vs. controls, respectively). 23299027 2013
Entrez Id: 93
Gene Symbol: ACVR2B
ACVR2B
0.100 Biomarker group HPO
Entrez Id: 81794
Gene Symbol: ADAMTS10
ADAMTS10
0.100 Biomarker group HPO
Entrez Id: 84890
Gene Symbol: ADO
ADO
0.010 Biomarker group BEFREE The CHB that is a major challenge for closure of VSDs is less common with soft, specially designed ADO II, which does not compress the conducting system. 24130123 2017
Entrez Id: 54806
Gene Symbol: AHI1
AHI1
0.100 GeneticVariation group CLINVAR
Entrez Id: 10000
Gene Symbol: AKT3
AKT3
0.100 Biomarker group HPO
Entrez Id: 213
Gene Symbol: ALB
ALB
0.010 AlteredExpression group BEFREE Increased levels of ELF SP-B were found in all defects, increased myeloperoxidase activity in all except the TOF, and increased levels of ELF albumin and SP-A only in ASD/VSD patients. 29281616 2018
Entrez Id: 139285
Gene Symbol: AMER1
AMER1
0.100 Biomarker group HPO
Entrez Id: 29123
Gene Symbol: ANKRD11
ANKRD11
0.100 Biomarker group HPO
Entrez Id: 348
Gene Symbol: APOE
APOE
0.010 GeneticVariation group BEFREE Infants with ventricular septal defect (VSD), tetralogy of Fallot (TOF), transposition of the great arteries (TGA), and hypoplastic left heart syndrome (HLHS) in a study of apolipoprotein E (APOE) polymorphisms, and neurodevelopmental outcome underwent neurodevelopmental and genetic evaluation at 4 years of age. 20951391 2010
Entrez Id: 351
Gene Symbol: APP
APP
0.010 Biomarker group BEFREE This study was designed to validate thrombospondin 1 (TSP-1), vascular endothelial-cadherin complex (VE-cad), insulin-like growth factor 2 (IGF-2), and amyloid precursor protein (APP) and assess their diagnostic value in ventricular septal defect (VSD). 28553678 2017
Entrez Id: 372
Gene Symbol: ARCN1
ARCN1
0.100 Biomarker group HPO
Entrez Id: 57514
Gene Symbol: ARHGAP31
ARHGAP31
0.100 Biomarker group HPO
Entrez Id: 8289
Gene Symbol: ARID1A
ARID1A
0.100 GeneticVariation group CLINVAR
Entrez Id: 57492
Gene Symbol: ARID1B
ARID1B
0.100 Biomarker group HPO
Entrez Id: 410
Gene Symbol: ARSA
ARSA
0.010 Biomarker group BEFREE Forty ASA physical status I/II pediatric patients scheduled for interventricular septal defect repair or interatrial septal defect repair, were randomly divided into two groups (20 each): intravenous induction group (Group C) and inhalational sevoflurane anesthesia induction group (Group D). 29509264 2018
Entrez Id: 414
Gene Symbol: ARSD
ARSD
0.020 Biomarker group BEFREE ASD and VSD patients have abnormal heart rate responses to exercise after surgical closure, which indicates a need of change in the preoperative information given to these patients and their parents before surgical defect closure. 28592193 2017
Entrez Id: 414
Gene Symbol: ARSD
ARSD
0.020 GeneticVariation group BEFREE Patients were divided into ventricular septal defect (VSD) group and AP group (ie, patients with ASD or PFO) based on the type of defects. 30444273 2018
Entrez Id: 347527
Gene Symbol: ARSH
ARSH
0.010 Biomarker group BEFREE To determine whether such congenital cardiac malformations are part of the disease spectrum of genetically determined ASH, cardiac pathologic observations were made in eight patients with disproportionate septal thickening (ventricular septal to posterobasal left ventricular free wall thickness ratios of 1.5 to 2.5) and the following three categories of associated lesions: 1) parachute deformity of the mitral valve (occurring either as an isolated lesion or with ventricular septal defect, coarctation of the aorta, supravalvular ring of the left atrium, or double outlet right ventricle); 2) complete interruption of the aortic arch; and 3) ventricular septal defect. 1236779 1975
Entrez Id: 421
Gene Symbol: ARVCF
ARVCF
0.100 Biomarker group HPO
Entrez Id: 170302
Gene Symbol: ARX
ARX
0.100 Biomarker group HPO
Entrez Id: 431
Gene Symbol: ASD1
ASD1
0.010 Biomarker group BEFREE We evaluated a pedigree with 16 family members, 1 with an atrial septal defect, 1 with a ventricular septal defect, and 3 with AF; we performed whole exome sequencing in 3 affected family members. 27756709 2017